Delivery Order SPE2DB22D2006-SPE2DB24FW2LL

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,389.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used for cardiovascular health, with a delivery order completion date of December 13, 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Repatha 140mg/ml 2s medication. The contract, valued at $8,415.84, is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of November 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,525.26 firm fixed price delivery order is for the supply of Repatha, a 140 mg/mL injectable medication, to support military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up...
This federal contract award, valued at $43,022.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the supply of Repatha 140 mg/ml SureClick medication. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,934.27 firm fixed-price delivery order is for Repatha, a 140 mg/mL injectable medication, with a completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Repatha (140 mg/mL) in an amount not to exceed $2,957.24. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Repatha, a specialty medication used to treat high cholesterol, awarded to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $1,156.57, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The DLA IDC enables the government to efficiently procure a comprehensive range...
This federal contract award, with a ceiling value of $1,694.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication. The award is a delivery order and the pricing type is firm fixed price. The contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,812.85 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,270.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml syringes, a specialty medication used for cardiovascular health treatment. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2LL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the medication Repatha (140 mg/mL). The award, valued at $16,601.13, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, potentially worth up to $999,999,999 through December 2025. The contract does not have a set-aside designation and is for a firm fixed-price delivery order with an ultimate completion date of August 5, 2024. This contract supports the supply of critical medical commodities, including specialty medications, to military treatment facilities and other federal healthcare providers nationwide.

Generated 11/1/24, 9:32 AM